- Triple vote of confidence in Sanlam Umbrella Fund The Institute of Retirement Funds Africa (IRFA) has awarded the Sanlam Umbrella Fund the Best in Class Trophy for Investment Practice, the Best in Class Trophy for Governance, the Gold Standard Certificate for Excellence in a Communication Project and a Special Merit Award in the 2017 IRFA Best Practices Industry Awards.
- Tips to take stock of your investments When last did you perform a financial health check by reviewing your investments? It’s important to occasionally take stock to assess whether or not you are on track to reach your goals, says Wanita Isaacs, head of investor education at Allan Gray.
- The balanced solution that’s far from passive By Kingsley Williams, CIO of Satrix. As investors, we’re all looking for the same thing: a certain outcome and a smooth ride to that destination. On top of that, we also want maximum returns with minimum risk. Sounds impossible? Over the short-term perhaps. But over the medium to long term it’s not that far-fetched. The...
- New study shows xylitol could help to control the growth of skin microbes A recently published study has shown that XIVIA Xylitol has a positive effect on skin microbial growth. The study titled ‘Evaluation of xylitol as an agent that controls the growth of skin microbes: Staphylococcus aureus, Staphylococcus epidermidis, and Cutibacterium acnes’ was published in the Korean Journal of Microbiology. Wood-based sweetener The researchers’ aim was to...
- Local and global gold demand at record levels Gold has generally held its status as an investment haven in times of global uncertainty, disparate economic growth across countries and particularly when geopolitics take the centre stage as they have done in recent years.
- Twin Peaks now law - a sad day for consumers? The controversial “Twin Peaks” regulatory system is now law with the signing of the Financial Sector Regulation Act by President Zuma on 21 August 2017 “and it is a sad day for consumers of financial services and for SA’s economy,” says the Free Market Foundation (FMF).
- Do not take on more risk, investors in South Africa warned By Tom Elliott, deVere Group’s International Investment Strategist Now is not the time to take on more risk. Diversify your investments and sit still. That is the message that I gave in a series of briefings, presentations and media interviews during a recent tour of Johannesburg and Cape Town. It is my view that many...
- R6 billion in revenue lost due to illicit alcohol The South African economy suffered a fiscal loss of R6.4 billion (US$492 million) in 2017 due to illicit alcohol activities, which generate annual revenue of R12.9 billion and go unregulated.
- Uso – scientifically formulated for African skin Uso by African Dermal Science, a proudly South African anti-ageing skin care brand, hit the market in 2018. The products are specifically formulated for Africans and the African climate. The brand name was inspired by the Zulu word Ubuso, which means a celebration of who we are as Africans. Dr Theo Mothoa-Frendo, a black female...
- South Africa’s first guilt-free protein ice cream Skinny Scoop has launched a first of its kind sugar-free protein ice cream. The product is the latest entrant in the Food Review/Symrise New Product Competition.

Industry Jobs

23 Sep 2020

Merck expands its ADC manufacturing capabilities

Merck has announced a € 59 million expansion of its HPAPI and ADC manufacturing capabilities and capacity at its facility…

Merck expands its ADC manufacturing capabilities

Merck has announced a € 59 million expansion of its HPAPI and ADC manufacturing capabilities and capacity at its facility near Madison, Wisconsin, USA. This investment will allow large-scale manufacturing of increasingly potent compounds for therapies that have the potential to treat cancer. Completion is expected by mid-2022 and should…

20 Jun 2018

Novartis brings over US$149 million GDP benefits to SA

International pharmaceutical company Novartis, already heavily invested in science and healthcare development partnerships across the continent, contributes around US$150 million…

Novartis brings over US$149 million GDP benefits to SA

International pharmaceutical company Novartis, already heavily invested in science and healthcare development partnerships across the continent, contributes around US$150 million to South African GDP each year, the company’s new CEO has revealed.

Visit the official COVID-19 government website to stay informed: sacoronavirus.co.za